A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Boston Scientific Corp stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 285,690 shares of BSX stock, worth $25.8 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
285,690
Previous 274,919 3.92%
Holding current value
$25.8 Million
Previous $21.2 Million 13.08%
% of portfolio
0.24%
Previous 0.22%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$72.96 - $84.0 $785,852 - $904,764
10,771 Added 3.92%
285,690 $23.9 Million
Q2 2024

Aug 13, 2024

BUY
$67.33 - $77.71 $1.48 Million - $1.71 Million
21,989 Added 8.69%
274,919 $21.2 Million
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $720,806 - $858,710
-12,514 Reduced 4.71%
252,930 $17.3 Million
Q4 2023

Feb 13, 2024

BUY
$48.64 - $57.81 $4.7 Million - $5.59 Million
96,613 Added 57.22%
265,444 $15.3 Million
Q3 2023

Nov 13, 2023

SELL
$50.19 - $54.68 $316,096 - $344,374
-6,298 Reduced 3.6%
168,831 $8.91 Million
Q2 2023

Aug 11, 2023

SELL
$49.72 - $54.64 $356,840 - $392,151
-7,177 Reduced 3.94%
175,129 $9.47 Million
Q1 2023

May 10, 2023

BUY
$45.09 - $50.03 $1.69 Million - $1.88 Million
37,553 Added 25.94%
182,306 $9.12 Million
Q4 2022

Feb 13, 2023

BUY
$39.56 - $47.22 $1.56 Million - $1.86 Million
39,410 Added 37.41%
144,753 $6.7 Million
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $1.3 Million - $3.89 Million
-35,476 Reduced 25.19%
105,343 $4.08 Million
Q2 2022

Aug 12, 2022

BUY
$35.24 - $47.1 $163,266 - $218,214
4,633 Added 3.4%
140,819 $5.25 Million
Q1 2022

May 10, 2022

SELL
$40.9 - $45.1 $99,100 - $109,277
-2,423 Reduced 1.75%
136,186 $6.03 Million
Q4 2021

Feb 11, 2022

BUY
$38.07 - $44.87 $5.28 Million - $6.22 Million
138,609 New
138,609 $5.96 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track B. Metzler Seel. Sohn & Co. Ag Portfolio

Follow B. Metzler Seel. Sohn & Co. Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.